SCHEMBL5956835

SCHEMBL5956835

COC(=O)c1cc2c(cc1Cl)C(=O)CCS2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.52
ALDH1A1 P00352 4/20 0.52
HTT P42858 2/20 0.47
VHL P40337 1/20 0.47
ELOC Q15369 1/20 0.47
ELOB Q15370 1/20 0.47
SERPINH1 P50454 1/20 0.40
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 2/20 0.34
ABL1 P00519 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5956466 0.84 ALDH1A1 (0.54) KDM4EALDH1A1HTTVHLELOC
SCHEMBL5956723 0.83 KDM4E (0.68) KDM4EALDH1A1HTTVHLELOC
SCHEMBL10364205 0.77 VHL (0.62) KDM4EALDH1A1HTTVHLELOC
SCHEMBL22714572 0.77 KDM4E (0.77) KDM4EALDH1A1HTTVHLELOC
SCHEMBL24362706 0.74 SLC6A2 (0.41) ALDH1A1HTTGAAMEN1KMT2A
SCHEMBL31247524 0.74 KDM4E (0.60) KDM4EALDH1A1HTTVHLELOC
SCHEMBL15689798 0.74 MAOA (0.44) KDM4EALDH1A1HTTSERPINH1GAA
SCHEMBL1091065 0.74 KDM4E (0.60) KDM4EALDH1A1HTTVHLELOC
SCHEMBL2263868 0.74 ALDH1A1 (0.53) KDM4EALDH1A1HTTVHLELOC
SCHEMBL9511327 0.72 GAA (0.45) KDM4EALDH1A1HTTSERPINH1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270570-B1 AMIDE COMPOUNDS AND USE THEREOF MITSUBISHI PHARMA CORP (JP) 2006-05-31 EP disclosed
US-6933305-B2 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2005-08-23 US disclosed
US-20030158413-A1 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2003-08-21 US disclosed
EP-1270570-A1 AMIDE COMPOUNDS AND USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158413-A1 Amide compounds and use thereof ROCK2, ROCK1, RHOT2 KDM4E 1686/4885ALDH1A1 2624/4885HTT 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.